• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期酶替代疗法可改善腺苷脱氨酶缺乏型小鼠的听力和免疫缺陷。

Early Enzyme Replacement Therapy Improves Hearing and Immune Defects in Adenosine Deaminase Deficient-Mice.

机构信息

Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

Developmental and Stem Cell Biology Program, Hospital for Sick Children, Toronto, ON, Canada.

出版信息

Front Immunol. 2019 Mar 13;10:416. doi: 10.3389/fimmu.2019.00416. eCollection 2019.

DOI:10.3389/fimmu.2019.00416
PMID:30918508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6424861/
Abstract

Inherited defects in adenosine deaminase (ADA) cause severe immune deficiency, which can be corrected by ADA enzyme replacement therapy (ERT). Additionally, ADA-deficient patients suffer from hearing impairment. We hypothesized that ADA-deficient (-/-) mice also exhibit hearing abnormalities and that ERT from an early age will improve the hearing and immune defects in these mice. Auditory brainstem evoked responses, organ weights, thymocytes numbers, and subpopulations, lymphocytes in peripheral blood as well as T lymphocytes in spleen were analyzed in ADA-/- and ADA-proficient littermate post-partum (pp). The cochlea was visualized by scanning electron microscopy (SEM). The effects of polyethylene glycol conjugated ADA (PEG-ADA) ERT or 40% oxygen initiated at 7 days pp on the hearing and immune abnormalities were assessed. Markedly abnormal hearing thresholds responses were found in ADA-/- mice at low and medium tone frequencies. SEM demonstrated extensive damage to the cochlear hair cells of ADA-/- mice, which were splayed, short or missing, correlating with the hearing deficits. The hearing defects were not reversed when hypoxia in ADA-/- mice was corrected. Progressive immune abnormalities were detected in ADA-/- mice from 4 days pp, initially affecting the thymus followed by peripheral lymphocytes and T cells in the spleen. ERT initiated at 7 days pp significantly improved the hearing of ADA-/- mice as well as the number of thymocytes and T lymphocytes, although not all normalized. ADA deficiency is associated with hearing deficits and damage to cochlear hair cells. Early initiation of ERT improves the hearing and immune abnormalities.

摘要

腺苷脱氨酶(ADA)遗传缺陷导致严重免疫缺陷,可以通过 ADA 酶替代疗法(ERT)纠正。此外,ADA 缺陷患者还会遭受听力损伤。我们假设 ADA 缺陷(-/-)小鼠也表现出听力异常,并且早期的 ERT 将改善这些小鼠的听力和免疫缺陷。在产后(pp)时,分析 ADA-/-和 ADA 功能正常的同窝仔鼠的听觉脑干诱发反应、器官重量、胸腺细胞数量和亚群、外周血中的淋巴细胞以及脾中的 T 淋巴细胞。通过扫描电子显微镜(SEM)观察耳蜗。评估聚乙二醇缀合 ADA(PEG-ADA)ERT 或 7 天时开始的 40%氧气对听力和免疫异常的影响。ADA-/- 小鼠在低频和中频时发现明显异常的听力阈值反应。SEM 显示 ADA-/- 小鼠的耳蜗毛细胞广泛受损,毛细胞张开、缩短或缺失,与听力缺陷相关。当 ADA-/- 小鼠的缺氧得到纠正时,听力缺陷并未逆转。ADA-/- 小鼠从第 4 天开始出现进行性免疫异常,最初影响胸腺,随后影响外周淋巴细胞和脾中的 T 细胞。ERT 从第 7 天开始显著改善 ADA-/- 小鼠的听力以及胸腺细胞和 T 淋巴细胞的数量,尽管并非所有都正常化。ADA 缺乏与听力缺陷和耳蜗毛细胞损伤有关。早期开始 ERT 可改善听力和免疫异常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/8270cf03092b/fimmu-10-00416-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/eb603ac880aa/fimmu-10-00416-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/ea0528ec5e20/fimmu-10-00416-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/832a16a2abc5/fimmu-10-00416-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/b8e4cd326ca8/fimmu-10-00416-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/b3efee3d91e4/fimmu-10-00416-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/8270cf03092b/fimmu-10-00416-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/eb603ac880aa/fimmu-10-00416-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/ea0528ec5e20/fimmu-10-00416-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/832a16a2abc5/fimmu-10-00416-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/b8e4cd326ca8/fimmu-10-00416-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/b3efee3d91e4/fimmu-10-00416-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665a/6424861/8270cf03092b/fimmu-10-00416-g0006.jpg

相似文献

1
Early Enzyme Replacement Therapy Improves Hearing and Immune Defects in Adenosine Deaminase Deficient-Mice.早期酶替代疗法可改善腺苷脱氨酶缺乏型小鼠的听力和免疫缺陷。
Front Immunol. 2019 Mar 13;10:416. doi: 10.3389/fimmu.2019.00416. eCollection 2019.
2
Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy.ADA-SCID 小鼠接受酶替代治疗后的代谢物和胸腺细胞发育缺陷。
Sci Rep. 2021 Dec 1;11(1):23221. doi: 10.1038/s41598-021-02572-w.
3
Comparison of elapegademase and pegademase in ADA-deficient patients and mice.ADA 缺乏症患者和小鼠中 elapegademase 与 pegademase 的比较。
Clin Exp Immunol. 2020 May;200(2):176-184. doi: 10.1111/cei.13420. Epub 2020 Feb 9.
4
ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.ADA 缺乏症:临床和实验室特征及转归评估。
J Clin Immunol. 2018 May;38(4):484-493. doi: 10.1007/s10875-018-0496-9. Epub 2018 May 9.
5
Effects of enzyme replacement therapy on immune function in ADA deficiency patient.酶替代疗法对腺苷脱氨酶缺乏症患者免疫功能的影响。
Clin Immunol. 2015 Dec;161(2):391-3. doi: 10.1016/j.clim.2015.06.011. Epub 2015 Jun 27.
6
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID.ADA 缺陷性 SCID 中腺苷代谢和 CD39/CD73 腺苷能机制的改变导致 Treg 细胞功能丧失和自身免疫。
Blood. 2012 Feb 9;119(6):1428-39. doi: 10.1182/blood-2011-07-366781. Epub 2011 Dec 19.
7
Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency.临床前研究展示慢病毒载体介导的腺苷脱氨酶缺乏症模型免疫和代谢异常的纠正。
Mol Ther. 2014 Mar;22(3):607-622. doi: 10.1038/mt.2013.265. Epub 2013 Nov 20.
8
Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.腺苷脱氨酶缺乏症患者的肺泡蛋白沉积症。
J Allergy Clin Immunol. 2012 Jun;129(6):1588-93. doi: 10.1016/j.jaci.2012.02.003. Epub 2012 Mar 10.
9
T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.聚乙二醇修饰的腺苷脱氨酶治疗后腺苷脱氨酶缺陷型重症联合免疫缺陷中的T淋巴细胞个体发生
J Clin Invest. 1993 Aug;92(2):596-602. doi: 10.1172/JCI116626.
10
First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.腺苷脱氨酶缺乏症重症联合免疫缺陷病患者中首例浆母细胞淋巴瘤的发生及文献复习。
Front Immunol. 2018 Feb 2;9:113. doi: 10.3389/fimmu.2018.00113. eCollection 2018.

引用本文的文献

1
Two Unrelated Iranian Patients with Adenosine Deaminase 2 Deficiency: A Case Report and Review of Treatment.两名无关的腺苷脱氨酶2缺乏症伊朗患者:病例报告及治疗综述
Case Reports Immunol. 2024 Aug 12;2024:4380689. doi: 10.1155/2024/4380689. eCollection 2024.
2
Inborn Errors of Purine Salvage and Catabolism.嘌呤补救和分解代谢的先天性缺陷。
Metabolites. 2023 Jun 24;13(7):787. doi: 10.3390/metabo13070787.
3
Multiple genetic variants involved in both autoimmunity and autoinflammation detected in Chinese patients with sporadic Meniere's disease: a preliminary study.

本文引用的文献

1
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.腺苷脱氨酶缺乏症所致严重联合免疫缺陷的管理共识方法。
J Allergy Clin Immunol. 2019 Mar;143(3):852-863. doi: 10.1016/j.jaci.2018.08.024. Epub 2018 Sep 5.
2
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations.腺苷脱氨酶(ADA)缺陷型重症联合免疫缺陷(SCID):分子发病机制与临床表现
J Clin Immunol. 2017 Oct;37(7):626-637. doi: 10.1007/s10875-017-0433-3. Epub 2017 Aug 25.
3
Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.
在中国散发性梅尼埃病患者中检测到与自身免疫和自身炎症均相关的多个基因变异:一项初步研究。
Front Neurol. 2023 May 18;14:1159658. doi: 10.3389/fneur.2023.1159658. eCollection 2023.
4
Purinergic Signalling in the Cochlea.嘌呤能信号在耳蜗中的作用。
Int J Mol Sci. 2022 Nov 28;23(23):14874. doi: 10.3390/ijms232314874.
5
MEFV, IRF8, ADA, PEPD, and NBAS gene variants and elevated serum cytokines in a patient with unilateral sporadic Meniere's disease and vascular congestion over the endolymphatic sac.一名单侧散发性梅尼埃病且内淋巴囊存在血管充血患者的MEFV、IRF8、ADA、PEPD和NBAS基因变异及血清细胞因子升高
J Otol. 2022 Jul;17(3):175-181. doi: 10.1016/j.joto.2022.03.001. Epub 2022 Mar 15.
6
The Use of Induced Pluripotent Stem Cells to Study the Effects of Adenosine Deaminase Deficiency on Human Neutrophil Development.利用诱导多能干细胞研究腺苷脱氨酶缺乏对人中性粒细胞发育的影响。
Front Immunol. 2021 Oct 28;12:748519. doi: 10.3389/fimmu.2021.748519. eCollection 2021.
7
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy.婴儿期起病庞贝病患者早期酶替代治疗后的听力特征。
Orphanet J Rare Dis. 2021 Aug 5;16(1):348. doi: 10.1186/s13023-021-01817-1.
8
Metabolic Aspects of Adenosine Functions in the Brain.大脑中腺苷功能的代谢方面
Front Pharmacol. 2021 May 14;12:672182. doi: 10.3389/fphar.2021.672182. eCollection 2021.
9
Ultrasonic bone removal from the ossicular chain affects cochlear structure and function.超声从听骨链移除会影响耳蜗结构和功能。
J Otolaryngol Head Neck Surg. 2021 Apr 2;50(1):23. doi: 10.1186/s40463-021-00491-4.
10
Comparison of elapegademase and pegademase in ADA-deficient patients and mice.ADA 缺乏症患者和小鼠中 elapegademase 与 pegademase 的比较。
Clin Exp Immunol. 2020 May;200(2):176-184. doi: 10.1111/cei.13420. Epub 2020 Feb 9.
腺苷脱氨酶缺乏症患者的长期预后:单中心经验。
J Clin Immunol. 2017 Aug;37(6):582-591. doi: 10.1007/s10875-017-0421-7. Epub 2017 Jul 26.
4
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients.腺苷代谢改变导致 ADA 缺陷型小鼠和患者的行为和神经功能障碍。
Sci Rep. 2017 Jan 11;7:40136. doi: 10.1038/srep40136.
5
Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells.对来自一名患有MYO7A突变的失聪患者的诱导多能干细胞进行基因校正,可使所衍生的毛细胞样细胞在形态和功能上得到恢复。
Stem Cells Transl Med. 2016 May;5(5):561-71. doi: 10.5966/sctm.2015-0252. Epub 2016 Mar 24.
6
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.美国11个筛查项目中对重症联合免疫缺陷的新生儿筛查。
JAMA. 2014 Aug 20;312(7):729-38. doi: 10.1001/jama.2014.9132.
7
Time course of cochlear injury discharge (excitotoxicity) determined by ABR monitoring of contralateral cochlear events.通过对侧耳蜗事件的ABR监测确定的耳蜗损伤放电(兴奋性毒性)的时间进程。
Hear Res. 2014 Sep;315:34-9. doi: 10.1016/j.heares.2014.06.002. Epub 2014 Jun 26.
8
Pulmonary alveolar proteinosis in adenosine deaminase-deficient mice.腺苷脱氨酶缺陷小鼠中的肺泡蛋白沉积症
J Allergy Clin Immunol. 2014 May;133(5):1467-71, 1471.e1-4. doi: 10.1016/j.jaci.2013.11.029. Epub 2014 Jan 15.
9
Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏症的研究进展及治疗策略
Curr Opin Allergy Clin Immunol. 2013 Dec;13(6):630-8. doi: 10.1097/ACI.0000000000000006.
10
Characteristic scapular and rib changes on chest radiographs of children with ADA-deficiency SCIDS in the first year of life.ADA 缺陷重症联合免疫缺陷病患儿在生命的第一年的胸部 X 线片上的特征性肩胛和肋骨改变。
Pediatr Radiol. 2013 Mar;43(5):589-92. doi: 10.1007/s00247-012-2564-2. Epub 2012 Nov 24.